tiprankstipranks
Advertisement

IGRO - ETF AI Analysis

Compare

Top Page

IGRO

iShares International Dividend Growth ETF (IGRO)

Rating:62Neutral
Price Target:
IGRO’s rating reflects a solid mix of high-quality international dividend growers, led by strong holdings like Novartis and Toyota, which bring robust financial health, positive earnings sentiment, and supportive technical trends to the portfolio. Banks such as Royal Bank of Canada, Toronto Dominion, and Mitsubishi UFJ also contribute positively, though their leverage and occasional overbought or cash flow concerns, along with valuation and technical caution around names like Roche and British American Tobacco, slightly temper the overall picture. The main risk factor is the fund’s meaningful exposure to financials and a few large individual positions, which can increase sensitivity to sector-specific and valuation-related swings.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and in recent months, showing positive momentum for investors.
Global Diversification
Holdings spread across many countries, including Japan, the U.S., Europe, and other regions, help reduce the impact of problems in any single market.
Low Expense Ratio
The fund’s relatively low annual fee means more of the ETF’s returns stay in investors’ pockets over time.
Negative Factors
Heavy Financial Sector Exposure
A large portion of the portfolio is in financial companies, which can make the fund more sensitive to interest rate and banking sector risks.
Mixed Performance Among Top Holdings
While several major positions have shown strong or steady gains, a few key holdings have been weak recently, which can drag on overall returns.
Concentration in Developed Markets
Most of the ETF’s assets are in developed countries, limiting potential benefits from faster-growing emerging markets.

IGRO vs. SPDR S&P 500 ETF (SPY)

IGRO Summary

IGRO is the iShares International Dividend Growth ETF, which follows the Morningstar Global ex-US Dividend Growth index. It invests in companies outside the United States that have a history of steadily increasing their dividend payments. The fund holds well-known names like Nestlé, Novartis, Toyota, and Royal Bank of Canada, spread across many countries and sectors. Someone might invest in IGRO to diversify beyond the U.S. and seek a mix of income and long-term growth from stable global companies. A key risk is that international stocks can go up and down with global markets and currency changes.
How much will it cost me?The iShares International Dividend Growth ETF (IGRO) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index of international dividend growth companies.
What would affect this ETF?The iShares International Dividend Growth ETF (IGRO) could benefit from global economic recovery and increased demand for dividend-paying stocks, especially in sectors like financials, healthcare, and utilities, which make up a significant portion of its holdings. However, potential risks include currency fluctuations, geopolitical tensions, and slower economic growth in international markets, which could negatively impact the performance of its top holdings and overall portfolio. Changes in interest rates or regulatory policies in key regions could also influence the ETF's future returns.

IGRO Top 10 Holdings

IGRO leans heavily on global financials and healthcare, with Canadian banks and European drugmakers steering the ship. Royal Bank of Canada, Toronto-Dominion, and Japan’s Mitsubishi UFJ have been rising steadily, giving the fund a solid backbone of dividend-friendly lenders. On the healthcare side, Novartis and Roche are quietly boosting returns, while Sanofi looks more mixed and occasionally loses steam. Consumer giant Nestlé has been lagging, and Toyota’s recent softness isn’t helping, but overall the ETF’s diversified, ex-U.S. mix keeps any single name from dominating the story.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Roche Holding AG3.01%$39.41M$361.51B51.16%
73
Outperform
Novartis AG2.94%$38.40MCHF230.61B32.06%
80
Outperform
Nestlé SA2.85%$37.30MCHF208.89B10.64%
71
Outperform
Royal Bank Of Canada2.82%$36.88M$293.84B57.98%
75
Outperform
2.66%$34.84M
British American Tobacco2.61%$34.19M£95.34B-1.99%
71
Outperform
Toyota Motor2.34%$30.61M¥35.29T7.50%
80
Outperform
Toronto Dominion Bank2.22%$28.99M$205.29B65.68%
74
Outperform
Mitsubishi UFJ Financial Group2.19%$28.67M¥39.85T52.16%
76
Outperform
Sanofi2.12%$27.77M€90.34B-7.54%
75
Outperform

IGRO Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
89.25
Positive
100DMA
87.32
Positive
200DMA
84.82
Positive
Market Momentum
MACD
1.01
Negative
RSI
61.59
Neutral
STOCH
61.53
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IGRO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 91.27, equal to the 50-day MA of 89.25, and equal to the 200-day MA of 84.82, indicating a bullish trend. The MACD of 1.01 indicates Negative momentum. The RSI at 61.59 is Neutral, neither overbought nor oversold. The STOCH value of 61.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IGRO.

IGRO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.31B0.15%
62
Neutral
$9.19B0.07%
66
Neutral
$2.83B0.30%
58
Neutral
$2.42B0.54%
60
Neutral
$1.88B0.50%
61
Neutral
$1.83B0.85%
60
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IGRO
iShares International Dividend Growth ETF
92.38
16.25
21.35%
VIGI
Vanguard International Dividend Appreciation ETF
CWI
SPDR MSCI ACWI ex-US ETF
CGIC
Capital Group International Core Equity ETF
ILOW
AB International Low Volatility Equity ETF
WCMI
First Trust WCM International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement